BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN)
Clinical trials for BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN) explained in plain language.
Never miss a new study
Get alerted when new BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN) trials appear
Sign up with your email to follow new studies for BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Living Drug' trial offers hope for patients with aggressive blood cancers
Disease control Recruiting nowThis early-phase study is testing the safety of a new personalized cell therapy called CART123 for adults with advanced blood cancers that have returned or not responded to other treatments. Doctors will collect a patient's own immune cells, modify them in a lab to target cancer,…
Matched conditions: BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN)
Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Global hunt for answers to a mysterious cancer
Knowledge-focused Recruiting nowThis study is creating a large international database for a very rare blood cancer called BPDCN. It aims to collect information from about 200 patients about their diagnosis, treatments, and outcomes. The goal is to better understand the disease and use this data to help doctors …
Matched conditions: BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN)
Sponsor: Immune Oncology Research Institute • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:40 UTC